Guidance went up, not down; the contract book lengthened; a landmark acquisition closed and its integration proceeded on plan.
Read Article ›The discount as struck double-counts Argentina — once in the multiple and again in the reflex to distrust cash flows that are demonstrably Brent-linked and demonstrably deleveraging the balance sheet. The tape has earned back at least one of those two discounts.
Read Article ›The signed backlog says the consensus deceleration curve is too steep, and while that gap persists the stock can grind higher on upward revisions rather than on further multiple expansion. That is the constructive case, and it is a real one: bookings running ahead of revenue, ...
Read Article ›The central tension in Dexcom is whether its non-insulin type 2 expansion is a margin-accretive growth wave or a commoditization trap. The resolution is in the sequencing. The catalysts that drive the next several quarters — commercial coverage of all diabetics this summer, G7...
Read Article ›Summary T Mobile just delivered the strongest fundamental quarter in its history—accelerating account growth, raised guidance across every major metric, and a $3.6 billion increase to its 2026 shareholder return program. Yet the stock sits near $194, roughly 26% below its 52 w...
Read Article ›Stryker Corporation recently faced a significant cybersecurity incident that disrupted its global operations, particularly affecting its Microsoft environment. The company has been working diligently with third party experts and law enforcement to contain and neutralize the im...
Read Article ›